| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6245653
[patent_doc_number] => 20020046413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Transgenic mice containing BMP gene disruptions'
[patent_app_type] => new
[patent_app_number] => 09/897772
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19560
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20020046413.pdf
[firstpage_image] =>[orig_patent_app_number] => 09897772
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/897772 | Transgenic mice containing BMP gene disruptions | Jun 28, 2001 | Issued |
Array
(
[id] => 6283676
[patent_doc_number] => 20020108138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Transgenic mice containing RORgamma gene disruptions'
[patent_app_type] => new
[patent_app_number] => 09/895840
[patent_app_country] => US
[patent_app_date] => 2001-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20315
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20020108138.pdf
[firstpage_image] =>[orig_patent_app_number] => 09895840
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/895840 | Transgenic mice containing RORgamma gene disruptions | Jun 27, 2001 | Abandoned |
Array
(
[id] => 528260
[patent_doc_number] => 07183405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-27
[patent_title] => 'Compositions and methods for labeling oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 09/894423
[patent_app_country] => US
[patent_app_date] => 2001-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 5575
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/183/07183405.pdf
[firstpage_image] =>[orig_patent_app_number] => 09894423
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/894423 | Compositions and methods for labeling oligonucleotides | Jun 27, 2001 | Issued |
Array
(
[id] => 528260
[patent_doc_number] => 07183405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-27
[patent_title] => 'Compositions and methods for labeling oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 09/894423
[patent_app_country] => US
[patent_app_date] => 2001-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 5575
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/183/07183405.pdf
[firstpage_image] =>[orig_patent_app_number] => 09894423
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/894423 | Compositions and methods for labeling oligonucleotides | Jun 27, 2001 | Issued |
Array
(
[id] => 6536835
[patent_doc_number] => 20020137134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Methods for producing modified glycoproteins'
[patent_app_type] => new
[patent_app_number] => 09/892591
[patent_app_country] => US
[patent_app_date] => 2001-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13392
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137134.pdf
[firstpage_image] =>[orig_patent_app_number] => 09892591
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/892591 | Methods for producing modified glycoproteins | Jun 26, 2001 | Issued |
| 09/831106 | Adult t cell leukemia model animal | Jun 18, 2001 | Abandoned |
Array
(
[id] => 532993
[patent_doc_number] => 07179901
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-20
[patent_title] => 'Renal regulatory elements and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/311388
[patent_app_country] => US
[patent_app_date] => 2001-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 11373
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/179/07179901.pdf
[firstpage_image] =>[orig_patent_app_number] => 10311388
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/311388 | Renal regulatory elements and methods of use thereof | Jun 14, 2001 | Issued |
Array
(
[id] => 6157819
[patent_doc_number] => 20020146796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Mutated herpes simplex virus type 1 thymidine kinases and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/877381
[patent_app_country] => US
[patent_app_date] => 2001-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10757
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146796.pdf
[firstpage_image] =>[orig_patent_app_number] => 09877381
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/877381 | Mutated herpes simplex virus type 1 thymidine kinases and uses thereof | Jun 7, 2001 | Issued |
Array
(
[id] => 6016043
[patent_doc_number] => 20020102705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Regulatory sequences of the mouse villin gene - use in transgenesis'
[patent_app_type] => new
[patent_app_number] => 09/877935
[patent_app_country] => US
[patent_app_date] => 2001-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10168
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20020102705.pdf
[firstpage_image] =>[orig_patent_app_number] => 09877935
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/877935 | Regulatory sequences of the mouse villin gene—use in transgenesis | Jun 7, 2001 | Issued |
| 09/857671 | Cadherin-like polypeptides, methods and compositions related thereto | Jun 5, 2001 | Abandoned |
| 09/763995 | Factor 8 Homologue nucleic acids, polypeptides, methods, uses | May 28, 2001 | Abandoned |
Array
(
[id] => 5828549
[patent_doc_number] => 20020068345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => '98P7C3: homeodomain protein highly expressed in various cancers'
[patent_app_type] => new
[patent_app_number] => 09/866359
[patent_app_country] => US
[patent_app_date] => 2001-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 54641
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068345.pdf
[firstpage_image] =>[orig_patent_app_number] => 09866359
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/866359 | 98P7C3: homeodomain protein highly expressed in various cancers | May 23, 2001 | Abandoned |
Array
(
[id] => 1392595
[patent_doc_number] => 06533912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-03-18
[patent_title] => 'Increased throughput analysis of small compounds using multiple temporally spaced injections'
[patent_app_type] => B2
[patent_app_number] => 09/859840
[patent_app_country] => US
[patent_app_date] => 2001-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 10386
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/533/06533912.pdf
[firstpage_image] =>[orig_patent_app_number] => 09859840
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/859840 | Increased throughput analysis of small compounds using multiple temporally spaced injections | May 15, 2001 | Issued |
Array
(
[id] => 5991142
[patent_doc_number] => 20020100068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Transgenic mouse for targeted recombination mediated by modified Cre-ER'
[patent_app_type] => new
[patent_app_number] => 09/853033
[patent_app_country] => US
[patent_app_date] => 2001-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 20836
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20020100068.pdf
[firstpage_image] =>[orig_patent_app_number] => 09853033
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/853033 | Transgenic mouse for targeted recombination mediated by modified Cre-ER | May 10, 2001 | Issued |
Array
(
[id] => 6129703
[patent_doc_number] => 20020076777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/852067
[patent_app_country] => US
[patent_app_date] => 2001-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 22135
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20020076777.pdf
[firstpage_image] =>[orig_patent_app_number] => 09852067
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/852067 | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | May 9, 2001 | Issued |
| 09/720215 | Modularly constructed rna molecules having two sequence region types | May 1, 2001 | Abandoned |
Array
(
[id] => 6259799
[patent_doc_number] => 20020187474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Polymorphisms in the PNMT gene'
[patent_app_type] => new
[patent_app_number] => 09/845713
[patent_app_country] => US
[patent_app_date] => 2001-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23841
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187474.pdf
[firstpage_image] =>[orig_patent_app_number] => 09845713
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/845713 | Polymorphisms in the PNMT gene | May 1, 2001 | Issued |
Array
(
[id] => 6066577
[patent_doc_number] => 20020032912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'Method of identifying agents that alter the activity of the promoter sequence for corticotropin releasing-factor receptor CRF2a'
[patent_app_type] => new
[patent_app_number] => 09/847852
[patent_app_country] => US
[patent_app_date] => 2001-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4502
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20020032912.pdf
[firstpage_image] =>[orig_patent_app_number] => 09847852
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/847852 | Method of identifying agents that alter the activity of the promoter sequence for corticotropin releasing-factor receptor CRF2a | Apr 29, 2001 | Abandoned |
Array
(
[id] => 6258636
[patent_doc_number] => 20020187132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Cardiac gene transfer'
[patent_app_type] => new
[patent_app_number] => 09/846034
[patent_app_country] => US
[patent_app_date] => 2001-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8679
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187132.pdf
[firstpage_image] =>[orig_patent_app_number] => 09846034
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/846034 | Cardiac gene transfer | Apr 29, 2001 | Abandoned |
Array
(
[id] => 6797102
[patent_doc_number] => 20030175976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Clean synthetic vectors, plasmids, transgenic plants and plant parts containing them, and methods for obtaining them'
[patent_app_type] => new
[patent_app_number] => 09/845064
[patent_app_country] => US
[patent_app_date] => 2001-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 22515
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175976.pdf
[firstpage_image] =>[orig_patent_app_number] => 09845064
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/845064 | Clean synthetic vectors, plasmids, transgenic plants and plant parts containing them, and methods for obtaining them | Apr 26, 2001 | Abandoned |
